Company Filing History:
12 out of 8,684 
1 out of 4 
1 out of 1 Years Active: 2002-2021
Title: Jay Hooper: Innovator in Vaccine Development
Introduction
Jay Hooper is an accomplished inventor based in New Market, MD, known for his significant contributions to the field of vaccine development. With a portfolio of 14 patents, his work primarily focuses on creating advanced solutions for infectious diseases, particularly through innovative vaccine technologies.
Latest Patents
One of Hooper’s latest patents involves the development of Sin Nombre virus full-length M segment-based DNA vaccines. This innovation presents a synthetic, codon-optimized version of the Sin Nombre virus (SNV) full-length M gene that encodes a unique consensus amino acid sequence. By cloning this gene into a plasmid, Hooper has successfully created the first stable recombinant SNV full-length M gene, which has been shown to elicit neutralizing antibodies. This breakthrough offers promising potential for engineering vaccines that can effectively protect mammals against infections caused by the Sin Nombre virus.
Another notable patent of Hooper includes systems and methods for producing human polyclonal antibodies. This patent outlines a method that involves injecting a non-human animal with a DNA vaccine derived from a pathogen, followed by administering an adjuvant in a separate location. This process allows researchers to collect plasma from the animal after the injections and purify polyclonal antibodies, paving the way for novel therapeutic approaches against various pathogens.
Career Highlights
Jay Hooper has had an impactful career, working with organizations such as the United States Army and Sab, LLC. His expertise in vaccine technology has been essential in advancing public health measures through innovative solutions to combat infectious diseases.
Collaborations
Throughout his career, Hooper has collaborated with notable figures in the field, including Connie S. Schmaljohn and Alan L. Schmaljohn. These collaborations have fostered a productive exchange of ideas and advancements in vaccine research, further bolstering the effectiveness of their collective efforts.
Conclusion
With 14 patents under his name, Jay Hooper stands out as a leading inventor in the realm of vaccine development. His latest innovations hold potential for significant contributions to global health, particularly in the fight against infectious diseases. As he continues to develop groundbreaking technologies, Hooper exemplifies the spirit of invention and innovation that drives progress in the medical field.